NeuroOne Medical Technologies Corporation (NMTC)
USD 0.86
(0.0%)
USD 0.86
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -11.95 Million USD | -19.19% |
| 2022 | -10.03 Million USD | 1.83% |
| 2021 | -10.21 Million USD | -108.44% |
| 2020 | -4.9 Million USD | 15.67% |
| 2019 | -5.81 Million USD | -81.06% |
| 2018 | -3.21 Million USD | -4.5% |
| 2017 | -3.07 Million USD | -9321.12% |
| 2016 | -32.61 Thousand USD | -5.49% |
| 2015 | -30.91 Thousand USD | 13.92% |
| 2014 | -35.91 Thousand USD | -82.94% |
| 2013 | -19.63 Thousand USD | -42.95% |
| 2012 | -13.73 Thousand USD | 49.93% |
| 2011 | -27.42 Thousand USD | -353.81% |
| 2010 | -6044.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.88 Million USD | 14.88% |
| 2024 Q3 | -2.79 Million USD | 3.19% |
| 2024 Q1 | -3.39 Million USD | -7.13% |
| 2023 Q2 | -3.49 Million USD | -95.92% |
| 2023 FY | -11.95 Million USD | -19.19% |
| 2023 Q4 | -3.16 Million USD | 9.84% |
| 2023 Q1 | -1.78 Million USD | -27.44% |
| 2023 Q3 | -3.51 Million USD | -0.41% |
| 2022 Q3 | -2.76 Million USD | 9.75% |
| 2022 FY | -10.03 Million USD | 1.83% |
| 2022 Q4 | -1.4 Million USD | 49.29% |
| 2022 Q2 | -3.05 Million USD | -8.92% |
| 2022 Q1 | -2.8 Million USD | -6.25% |
| 2021 Q4 | -2.64 Million USD | 12.88% |
| 2021 FY | -10.21 Million USD | -108.44% |
| 2021 Q1 | -2.14 Million USD | -1725.34% |
| 2021 Q2 | -2.39 Million USD | -11.77% |
| 2021 Q3 | -3.03 Million USD | -26.69% |
| 2020 Q2 | -1.37 Million USD | 24.07% |
| 2020 Q1 | -1.81 Million USD | -34.02% |
| 2020 Q3 | -1.59 Million USD | -15.69% |
| 2020 FY | -4.9 Million USD | 15.67% |
| 2020 Q4 | -117.42 Thousand USD | 92.63% |
| 2019 Q1 | -1.07 Million USD | 4.14% |
| 2019 Q4 | -1.35 Million USD | 27.35% |
| 2019 Q3 | -1.86 Million USD | -22.47% |
| 2019 Q2 | -1.52 Million USD | -41.39% |
| 2019 FY | -5.81 Million USD | -81.06% |
| 2018 Q2 | -1.09 Million USD | 19.58% |
| 2018 Q4 | -1.12 Million USD | 4.26% |
| 2018 FY | -3.21 Million USD | -4.5% |
| 2018 Q3 | -1.17 Million USD | -6.81% |
| 2018 Q1 | -1.36 Million USD | -52.69% |
| 2017 FY | -3.07 Million USD | -9321.12% |
| 2017 Q4 | -893.79 Thousand USD | -0.57% |
| 2017 Q3 | -888.68 Thousand USD | -72.21% |
| 2017 Q2 | -516.05 Thousand USD | -182.51% |
| 2017 Q1 | -182.66 Thousand USD | -9310.97% |
| 2016 Q1 | -14.56 Thousand USD | -462.73% |
| 2016 Q2 | -4386.00 USD | 69.89% |
| 2016 Q4 | -1941.00 USD | 86.24% |
| 2016 Q3 | -14.1 Thousand USD | -221.66% |
| 2016 FY | -32.61 Thousand USD | -5.49% |
| 2015 FY | -30.91 Thousand USD | 13.92% |
| 2015 Q4 | -2589.00 USD | 86.13% |
| 2015 Q3 | -18.66 Thousand USD | -94.98% |
| 2015 Q2 | -9574.00 USD | 3.07% |
| 2015 Q1 | -9877.00 USD | -61.39% |
| 2014 Q3 | -16.01 Thousand USD | -348.96% |
| 2014 Q2 | -3568.00 USD | -38.13% |
| 2014 Q1 | -2583.00 USD | 45.39% |
| 2014 FY | -35.91 Thousand USD | -82.94% |
| 2014 Q4 | -6120.00 USD | 61.8% |
| 2013 Q2 | -2985.00 USD | -118.36% |
| 2013 Q4 | -4730.00 USD | 68.03% |
| 2013 Q3 | -14.79 Thousand USD | -395.64% |
| 2013 FY | -19.63 Thousand USD | -42.95% |
| 2013 Q1 | -1367.00 USD | 71.11% |
| 2012 Q1 | -15.45 Thousand USD | -274.65% |
| 2012 Q3 | -2286.00 USD | 58.58% |
| 2012 Q4 | -4731.00 USD | -106.96% |
| 2012 FY | -13.73 Thousand USD | 49.93% |
| 2012 Q2 | -5519.00 USD | 64.3% |
| 2011 Q3 | -1182.00 USD | 82.26% |
| 2011 Q4 | -4126.00 USD | -249.07% |
| 2011 Q1 | -547.00 USD | 89.48% |
| 2011 Q2 | -6662.00 USD | -1117.92% |
| 2011 FY | -27.42 Thousand USD | -353.81% |
| 2010 Q3 | -2779.00 USD | 0.0% |
| 2010 FY | -6044.00 USD | 0.0% |
| 2010 Q4 | -5198.00 USD | -87.05% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 16.752% |
| Cerus Corporation | -30.05 Million USD | 60.219% |
| OrthoPediatrics Corp. | -25.76 Million USD | 53.601% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -12.559% |
| Talis Biomedical Corporation | -66.81 Million USD | 82.107% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 30.879% |
| Inogen, Inc. | -109.38 Million USD | 89.071% |
| Spectral AI, Inc. | -12.98 Million USD | 7.923% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 80.899% |
| CVRx, Inc. | -43.1 Million USD | 72.264% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -238.868% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 3.804% |
| Orthofix Medical Inc. | -139.11 Million USD | 91.406% |
| Venus Concept Inc. | -28.3 Million USD | 57.769% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 77.872% |
| Bioventus Inc. | -81.72 Million USD | 85.371% |
| BrainsWay Ltd. | -4.92 Million USD | -142.648% |
| Envoy Medical, Inc. | -18.37 Million USD | 34.923% |
| electroCore, Inc. | -18.8 Million USD | 36.425% |
| IceCure Medical Ltd | -15.57 Million USD | 23.246% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 75.341% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 30.767% |
| MaxCyte, Inc. | -48.29 Million USD | 75.247% |
| Nexalin Technology, Inc. | -5.69 Million USD | -109.878% |
| PAVmed Inc | -68.79 Million USD | 82.622% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 78.864% |
| RxSight, Inc. | -50.08 Million USD | 76.13% |
| Sight Sciences, Inc. | -57.27 Million USD | 79.126% |
| SI-BONE, Inc. | -46.93 Million USD | 74.526% |
| TELA Bio, Inc. | -44.07 Million USD | 72.875% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 77.922% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 76.753% |
| LivaNova PLC | -68.49 Million USD | 82.547% |
| 908 Devices Inc. | -42.75 Million USD | 72.04% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 93.105% |
| Nemaura Medical Inc. | -9.59 Million USD | -24.596% |
| NeuroPace, Inc. | -27.17 Million USD | 56.005% |
| LENSAR, Inc. | -12.22 Million USD | 2.239% |
| Apyx Medical Corporation | -17.25 Million USD | 30.73% |
| Cutera, Inc. | -156.23 Million USD | 92.348% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -38.95% |
| BioSig Technologies, Inc. | -28.51 Million USD | 58.069% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 86.359% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 46.738% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 110.72% |
| Axonics, Inc. | -26.05 Million USD | 54.119% |
| Outset Medical, Inc. | -169.77 Million USD | 92.958% |
| IRIDEX Corporation | -10 Million USD | -19.469% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 89.049% |
| IRadimed Corporation | 20.03 Million USD | 159.67% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -45.0% |
| INVO Bioscience, Inc. | -6.76 Million USD | -76.666% |
| Telesis Bio, Inc. | -35.15 Million USD | 65.988% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 183.428% |
| Varex Imaging Corporation | 32.1 Million USD | 137.244% |
| Quipt Home Medical Corp. | 3.91 Million USD | 405.059% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1.465% |
| Pulmonx Corporation | -61.93 Million USD | 80.697% |
| Dynatronics Corporation | -2.27 Million USD | -425.957% |
| Modular Medical, Inc. | -17.52 Million USD | 31.797% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 18.333% |
| Semler Scientific, Inc. | 22.25 Million USD | 153.717% |
| InMode Ltd. | 195.66 Million USD | 106.11% |
| Bruker Corporation | 436.9 Million USD | 102.736% |
| Cytosorbents Corporation | -31.2 Million USD | 61.693% |
| DexCom, Inc. | 597.7 Million USD | 102.0% |
| Align Technology, Inc. | 643.33 Million USD | 101.858% |
| Viveve Medical, Inc. | -21.55 Million USD | 44.531% |
| ZimVie Inc. | -30.93 Million USD | 61.359% |
| Movano Inc. | -29.69 Million USD | 59.733% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 57.065% |
| Nexalin Technology, Inc. | -5.69 Million USD | -109.878% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -238.868% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 94.874% |
| Profound Medical Corp. | -28.61 Million USD | 58.222% |
| Insulet Corporation | 220 Million USD | 105.434% |
| enVVeno Medical Corporation | -25.23 Million USD | 52.63% |
| Surmodics, Inc. | -5.64 Million USD | -111.785% |
| iCAD, Inc. | -7.68 Million USD | -55.485% |
| Nuwellis, Inc. | -17.63 Million USD | 32.188% |
| Biotricity, Inc. | -8.82 Million USD | -35.42% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 90.448% |
| Aethlon Medical, Inc. | -12.63 Million USD | 5.392% |
| InspireMD, Inc. | -21.14 Million USD | 43.455% |
| PAVmed Inc. | -68.79 Million USD | 82.622% |
| BIOLASE, Inc. | -17.93 Million USD | 33.349% |
| Beyond Air, Inc. | -63 Million USD | 81.025% |
| FONAR Corporation | 16.53 Million USD | 172.301% |
| AxoGen, Inc. | -21.46 Million USD | 44.296% |
| Vivani Medical, Inc. | -26.96 Million USD | 55.664% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 166.267% |
| Inari Medical, Inc. | -14.03 Million USD | 14.8% |
| UFP Technologies, Inc. | 57.66 Million USD | 120.733% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -142.618% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -89.592% |
| Tenon Medical, Inc. | -15.72 Million USD | 23.983% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -59.958% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 72.006% |
| AdaptHealth Corp. | -598.4 Million USD | 98.002% |
| Sintx Technologies, Inc. | -13.35 Million USD | 10.501% |
| NanoVibronix, Inc. | -3.43 Million USD | -247.941% |
| Quanterix Corporation | -49.7 Million USD | 75.946% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1.465% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -3029.647% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 96.426% |
| TransMedics Group, Inc. | -28.72 Million USD | 58.383% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 49.368% |
| NeuroMetrix, Inc. | -7.15 Million USD | -67.171% |
| Hyperfine, Inc. | -48.11 Million USD | 75.153% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 81.615% |
| Biomerica, Inc. | -6.36 Million USD | -87.769% |
| Bone Biologics Corporation | -9.42 Million USD | -26.802% |
| AVITA Medical, Inc. | -40.4 Million USD | 70.409% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -15.944% |
| Silk Road Medical, Inc | -59.27 Million USD | 79.83% |